Emerging Pharma Trends that will Revolutionize the Healthcare Landscape in the Asia Pacific

USD 500

* Required Fields

USD 500

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.

Table of Contents

Emerging Pharma Trends that will Revolutionize the Healthcare Landscape in the Asia PacificVital Signs - July 2014This week's issue




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.